Packaging design

Home > PJ (current issue) > Letters | Search

The Pharmaceutical Journal
Vol 276 No 7404 p678
10 June 2006

This article
Reprint Photocopy

PDF 50K, Acrobat Reader

Letters

· Education (2)
· NHS funding
· Complementary medicine
· Electronic prescribing
· The profession
· Women in politics
· Packaging design
· Statutory Committee
· Annual general meeting
· Council expenses
· Regulation
· Section 60 Order
· Council election

Letters to the Editor

Packaging design

Waste makers

From Mr M. Yee, MRPharmS

The recent redesign of the Angettes pack surely was an exercise in waste making. The project failed. It was a disaster for ecology and it failed to conserve materials. The container for 28 tablets could hold many more tablets. Redesigning achieved only one thing: a job for someone, but what a waste of time and money and what disruption. Angettes was out of stock for six months.

Malcolm Yee
Oxford

BRISTOL-MYERS SQUIBB responds:

To comply with the Medicines (Child Safety) Regulations on child-resistant packaging, the blister packaging of Angettes (aspirin), marketed by Bristol-Myers Squibb, is currently being upgraded. We are developing a new blister packaging but it will be a few months before it will be available in the UK.

In the interim, Angettes is available in a bottle with a child-resistant closure, which meets the requirements of the regulations. This will help ensure product availability while the blister packaging is being improved.

Send your letter to The Editor

Previous Topic (Women in politics)
Next Topic (Statutory Committee)